The Enterprise Value as of December 2025 (TTM) for Piramal Pharma Limited (PPLPHARMA.NS) is 277.37B

According to Piramal Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 277.37B. This represents a change of -9.97% compared to the average of 308.10B of the last 4 quarters.

Piramal Pharma Limited (PPLPHARMA.NS) Historical Enterprise Value (quarterly & annually)

How has PPLPHARMA.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Piramal Pharma Limited over the last ten years is 236.21B. The current 277.37B Enterprise Value has changed 11.64% with respect to the historical average. Over the past ten years (40 quarters), PPLPHARMA.NS's Enterprise Value was at its highest in in the September 2024 quarter at 348.20B. The Enterprise Value was at its lowest in in the June 2021 quarter at 0.

Piramal Pharma Limited (PPLPHARMA.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Piramal Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Piramal Pharma Limited (PPLPHARMA.NS) Average Enterprise Value

How has PPLPHARMA.NS Enterprise Value performed in the past?

The current Enterprise Value of Piramal Pharma Limited (PPLPHARMA.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Piramal Pharma Limited (PPLPHARMA.NS) Enterprise Value vs. Peers

How is PPLPHARMA.NS’s Enterprise Value compared to its peers?

Piramal Pharma Limited’s Enterprise Value is greater than Syngene International Limited (256.83B), greater than Syngene International Limited (256.83B), greater than Piramal Enterprises Limited (254.86B), less than J. B. Chemicals & Pharmaceuticals Limited (286.37B), less than J. B. Chemicals & Pharmaceuticals Limited (286.37B), greater than Dr. Lal PathLabs Limited (243.53B), greater than Dr. Lal PathLabs Limited (243.53B), less than Inventurus Knowledge Solutions Ltd. (277.82B), less than Inventurus Knowledge Solutions Ltd. (277.82B), greater than AstraZeneca Pharma India Limited (225.53B),

Build a custom stock screener for Piramal Pharma Limited (PPLPHARMA.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Piramal Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Piramal Pharma Limited (PPLPHARMA.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Piramal Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.